HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PAZEO* safely and effectively. See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride ophthalm

First Page		Document Content
Date: 2016-04-27 08:32:13 Chemistry Medicine Organic chemistry Carboxylic acids Amines Olopatadine Dosage forms Allergic conjunctivitis Eye drop Benzalkonium chloride		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PAZEO* safely and effectively. See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride ophthalm Add to Reading List Source URL: ecatalog.alcon.com Download Document from Source Website File Size: 481,00 KB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PAZEO* safely and effectively. See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride ophthalm DocID: 1rcmh - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PAZEO* safely and effectively. See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride ophthalm DocID: 1qJA3 - View Document
	DESCRIPTION PATANOL® (olopatadine hydrochloride ophthalmic solution) 0.1% is a sterile ophthalmic solution containing olopatadine, a relatively selective H1 -receptor antagonist and inhibitor of histamine release from t DocID: NAo0 - View Document
	Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: DocID: COdJ - View Document
	CPDO Examination - Minicase 1 Patient findings: A 27-year-old female presents after an airbag injury to her right eye the previous day. Examination reveals a relative afferent pupillary defect and light-perception vision DocID: CO0u - View Document